These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8262737)

  • 1. Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.
    Taylor SA; Benedetti J; Schuller D; Richman SP; Broun GO; Hantel A
    Invest New Drugs; 1993; 11(2-3):227-9. PubMed ID: 8262737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.
    Hantel A; Tangen C; Gluck WL; Macdonald JS
    Invest New Drugs; 1994; 12(2):159-61. PubMed ID: 7860236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Jenkins TR; Tangen C; Macdonald JS; Weiss G; Chapman R; Hantel A
    Invest New Drugs; 1993 Nov; 11(4):329-31. PubMed ID: 8157474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.
    Allen A; Wolf M; Crawford ED; Davis MP; Natale RB; Barnett ML
    Invest New Drugs; 1992 Jul; 10(2):129-32. PubMed ID: 1500267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.
    Ravdin PM; Green S; Doroshow JH; Martino S
    Invest New Drugs; 1994; 12(4):333-6. PubMed ID: 7775136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
    Pazdur R; Bready B; Scalzo AJ; Brandof JE; Close DR; Kolbye S; Winn RJ
    Invest New Drugs; 1994; 12(3):263-5. PubMed ID: 7896547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.
    Zalupski MM; Benedetti J; Balcerzak SP; Hutchins LF; Belt RJ; Hantel A; Goodwin JW
    Invest New Drugs; 1993 Nov; 11(4):337-41. PubMed ID: 8157477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study.
    Sosman JA; Flaherty LE; Liu PY; Fletcher W; Thompson JA; Hantel A; Sondak V
    Invest New Drugs; 1995; 13(1):83-7. PubMed ID: 7499114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.
    Malviya VK; Liu PY; Goldberg DA; Hantel A; O'Toole RV; Roach RW; Conrad ME; Alberts DS
    Anticancer Drugs; 1996 Jul; 7(5):527-30. PubMed ID: 8862719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.
    Mattox DE; Clark GM; Balcerzak SP; O'Bryan RM; Oishi N; Stuckey WJ
    Invest New Drugs; 1984; 2(4):405-7. PubMed ID: 6511243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
    Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
    J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.
    Albain KS; Liu PY; Hantel A; Poplin EA; O'Toole RV; Wade JL; Maddox AM; Alberts DS
    Gynecol Oncol; 1995 Jun; 57(3):407-11. PubMed ID: 7774846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy.
    Ingle JN; Kuross SA; Mailliard JA; Loprinzi CL; Jung SH; Nelimark RA; Krook JE; Long HJ
    Cancer; 1994 Sep; 74(6):1733-8. PubMed ID: 8082075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.
    Williams SD; Birch R; Velez-Garcia E; Gams R
    Invest New Drugs; 1985; 3(3):311-3. PubMed ID: 4066226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study.
    Smith RE; Lew D; Rodriguez GI; Taylor SA; Schuller D; Ensley JF
    Invest New Drugs; 1996; 14(4):403-7. PubMed ID: 9157077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
    Huan SD; Natale RB; Stewart DJ; Sartiano GP; Stella PJ; Roberts JD; Symes AL; Finizio M
    Clin Cancer Res; 2000 Apr; 6(4):1333-6. PubMed ID: 10778959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
    Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
    Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
    Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
    Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.